。$四季教育(FEDU)$ $华富教育(WAFU)$查看全文
智通财经APP讯,先声药业(02096)发布公告,该公司与Kazia Therapeutics Limited(Kazia)合作的创新药SIM0395(Paxalisib)于2021年12月6日获得中国国家药品监督管理局签发的药物临床试验批准通知书,拟用于胶质母细胞瘤(GBM),包括新诊断和... 网页链接
$Kazia Therapeutics(KZIA)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001193125-24-177076 Act: 33 Size: 40 KB 网页链接
$Kazia Therapeutics(KZIA)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001193125-24-177078 Act: 33 Size: 40 KB 网页链接
$Kazia Therapeutics(KZIA)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001193125-24-177075 Act: 33 Size: 40 KB 网页链接
$Kazia Therapeutics(KZIA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-177072 Act: 34 Size: 30 KB 网页链接
$Kazia Therapeutics(KZIA)$ SC 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001213900-24-058695 Act: 34 Size: 76 KB 网页链接
$Kazia Therapeutics(KZIA)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-002024 Act: 33 Size: 1 KB 网页链接
$Kazia Therapeutics(KZIA)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001193125-24-172305 Act: 33 Size: 335 KB 网页链接
$Kazia Therapeutics(KZIA)$ F-1 Registration statement for certain foreign private issuers Accession Number: 0001193125-24-167200 Act: 33 Size: 510 KB 网页链接
$Kazia Therapeutics(KZIA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-166929 Act: 34 Size: 10 KB 网页链接
$Kazia Therapeutics(KZIA)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001193125-24-166931 Act: 33 Size: 20 KB 网页链接